Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2022-04-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a person or entity acquires a significant stake (typically 5% or more) in a listed company. This document details the shareholding status, changes in ownership, and the purpose of holding (management influence). It is a standard regulatory disclosure form, not an annual report, earnings release, or announcement of a report. Therefore, it falls under the 'Major Shareholding Notification' category.
2022-04-06 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) by a major shareholder (Kim Do-hyung) in the company 'Knotus'. This falls under the category of Major Shareholding Notification.
2022-04-06 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (DART system) used when an individual or entity acquires a significant stake (typically 5% or more) in a company. This falls under the category of Major Shareholding Notification.
2022-04-06 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding the cancellation or modification of a stock collateral agreement involving a major shareholder. It is a formal disclosure of a change in financial arrangements (collateral) related to share ownership. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Major Shareholding Notification' (which is for threshold changes), and it is a specific regulatory disclosure regarding capital/financing structure, it falls under the 'Regulatory Filings' (RNS) category as a fallback for miscellaneous corporate disclosures.
2022-04-04 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a correction to a previous disclosure about a stock collateral contract involving a major shareholder. It details changes in collateralized shares and debt status. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Major Shareholding Notification' (which is for ownership threshold changes), and it is a formal regulatory announcement regarding financing/collateral structure, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate disclosures.
2022-04-01 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's Representative Director (CEO). It details the outgoing and incoming directors, the reason for the change (resignation and management efficiency), and the date of the board resolution. This falls directly under the definition of Board/Management Information (MANG).
2022-03-31 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.